secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2026-07-23T21:00:13+00:00
Accession:  0001493152-26-034428
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions resolves all cybersecurity review items for FDA 510(k) submission; on track for H2 2026 filing
--------------------------------------------------------------------------------

- Completed independent third-party penetration testing; all cybersecurity review items resolved.
- 100% of medium-risk vulnerabilities remediated; low-risk reduced from 11 to 2 with risk-based justification.
- All 19 software bill of materials (SBOM) vulnerabilities fully resolved; documentation aligned with FDA guidance.
- 510(k) submission targeting codeine detection as initial indication; planned U.S. market entry in multi-billion-dollar drug screening market.
- Manufacturing partnership with Syrma Johari MedTech expected to deliver >40% production cost savings and ~20 ppt gross margin improvement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226034428/0001493152-26-034428-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226034428/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-034428

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer